Cleveland Clinic

Running trials

• Not yet recruiting

  Life Expectancy-informed Colorectal Cancer Screening

  NCT07141901· Source

• Not yet recruiting

  A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

  NCT07222956· PHASE2· Source

• Not yet recruiting

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· PHASE3· Source

• Not yet recruiting

  Wearable Technology in Heart Failure Patients

  NCT07650669· Source

• Not yet recruiting

  Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension

  NCT07218198· Source

• Recruiting

  Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease

  NCT07748962· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· PHASE3· Source

• Not yet recruiting

  Signatera Assessment in Early-Stage Endometrial Cancer

  NCT07339384· Source

• Not yet recruiting

  A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

  NCT06458907· Source

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· PHASE3· Source

• Recruiting

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· PHASE3· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· PHASE3· Source

• Recruiting

  Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.

  NCT07798323· Source

• Recruiting

  Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

  NCT07436299· Source

• Recruiting

  Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

  NCT07680283· Source

• Recruiting

  Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  NCT07804186· PHASE3· Source

• Not yet recruiting

  Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

  NCT07218575· PHASE2 PHASE3· Source

• Not yet recruiting

  GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

  NCT07747805· PHASE2· Source

• Recruiting

  A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

  NCT07214376· Source

• Recruiting

  Imaging in Semaglutide Study

  NCT07695454· Source

• Recruiting

  HCMR Re-Imaging Study

  NCT07054073· Source

• Recruiting

  A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  NCT07330258· Source

• Recruiting

  VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

  NCT07390344· Source

• Recruiting

  Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS

  NCT07442747· PHASE2· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· PHASE3· Source

• Recruiting

  Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  NCT07511361· PHASE2· Source

• Recruiting

  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  NCT07563881· PHASE3· Source

• Active, not recruiting

  Health-Related Quality of Life and Metabolic Outcomes in PCOS

  NCT07571915· Source

• Recruiting

  A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  NCT07101328· PHASE1· Source

• Recruiting

  A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

  NCT07553429· PHASE1 PHASE2· Source

• Recruiting

  Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  NCT07441694· PHASE1· Source

• Recruiting

  A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

  NCT07592689· PHASE3· Source

• Recruiting

  Longitudinal Validation of CIRC Technologies

  NCT07081711· Source

• Recruiting

  Humidity Asthma Interventions for Low Socioeconomic Status Children

  NCT07453667· Source

• Not yet recruiting

  The Canopy Cancer Collective Clinical Registry Protocol

  NCT07605702· Source

• Recruiting

  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  NCT07293351· PHASE1 PHASE2· Source

• Recruiting

  Healthy Aging in People With Epilepsy Program

  NCT06052605· Source

• Recruiting

  Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes

  NCT07509190· Source

• Recruiting

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· PHASE3· Source

• Recruiting

  Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study

  NCT07363343· Source

• Recruiting

  Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

  NCT07454174· Source

• Recruiting

  A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07258511· PHASE3· Source

• Recruiting

  Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

  NCT06875128· PHASE2· Source

• Recruiting

  Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

  NCT07096778· PHASE2· Source

• Recruiting

  Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

  NCT07232017· Source

• Recruiting

  Continuous Glucose Monitoring in Polycystic Ovarian Syndrome

  NCT07392476· Source

• Recruiting

  Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

  NCT07265947· PHASE2· Source

• Active, not recruiting

  A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  NCT07107945· PHASE3· Source

• Recruiting

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· PHASE3· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· PHASE3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure20 recruiting
• Lung cancer18 recruiting
• Colorectal cancer13 recruiting
• Coronary artery disease11 recruiting
• Ovarian cancer11 recruiting
• Parkinson disease11 recruiting
• Atrial fibrillation10 recruiting
• Gastric and esophageal cancer10 recruiting
• Epilepsy9 recruiting
• Multiple myeloma9 recruiting
• Bladder cancer8 recruiting
• Head and neck cancer8 recruiting
• High blood pressure8 recruiting
• Kidney cancer8 recruiting
• Myeloproliferative neoplasms8 recruiting
• Obesity8 recruiting
• Liver and biliary tract cancer7 recruiting
• Melanoma7 recruiting
• Pancreatic cancer7 recruiting
• Endometrial cancer6 recruiting
• Sarcoma6 recruiting
• Stroke6 recruiting
• Acute myeloid leukemia5 recruiting
• Childhood cancers5 recruiting
• Multiple sclerosis5 recruiting
• Triple-negative breast cancer5 recruiting
• Amyloidosis4 recruiting
• Cervical cancer4 recruiting
• Chronic lymphocytic leukaemia4 recruiting
• Hypertrophic cardiomyopathy4 recruiting
• Metastatic breast cancer4 recruiting
• Crohn's disease3 recruiting
• Diffuse large B-cell lymphoma3 recruiting
• Follicular lymphoma3 recruiting
• Idiopathic pulmonary fibrosis3 recruiting
• Myelodysplastic syndromes3 recruiting
• Polycystic kidney disease3 recruiting
• Prostate cancer3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Asthma2 recruiting
• Chronic kidney disease2 recruiting
• Chronic myeloid leukaemia2 recruiting
• COPD2 recruiting
• Diabetic eye disease2 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Glioblastoma2 recruiting
• Huntington's disease2 recruiting
• Mantle cell lymphoma2 recruiting
• Myasthenia gravis2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Retinitis pigmentosa2 recruiting
• Sickle cell disease2 recruiting
• Thyroid cancer2 recruiting
• Type 1 diabetes2 recruiting
• Ulcerative colitis2 recruiting
• ALS (motor neurone disease)1 recruiting
• Alzheimer disease1 recruiting
• Autism1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Depression1 recruiting
• Hepatitis B1 recruiting
• Hodgkin lymphoma1 recruiting
• Macular degeneration1 recruiting
• Mesothelioma1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Thalassaemia1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

  NCT06881836· PHASE2· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· PHASE3· Source

• Completed

  Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

  NCT06604442· PHASE4· Source

• Recruiting

  CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

  NCT06258447· Source

• Completed

  Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy

  NCT06533527· PHASE4· Source

• Completed

  Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

  NCT06460272· Source

• Recruiting

  Platform Clinical Study for Conquering Scleroderma

  NCT06195072· PHASE2· Source

• Completed

  A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

  NCT06188559· PHASE2· Source

• Completed

  Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

  NCT06235099· PHASE3· Source

• Completed

  Microbial Metabolites and Outcomes of Pregnancy Study

  NCT06362356· Source

• Completed

  Testing the Effectiveness of WW Clinic GLP1

  NCT06034457· Source

• Completed

  Using Shared Decision Making to Improve Kidney Transplantation Rates

  NCT06141499· Source

• Recruiting

  Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT05696626· PHASE3· Source

• Completed

  HEAL-LAA Clinical Trial

  NCT05809596· Source

• Completed

  The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease

  NCT05905302· Source

• Completed

  Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

  NCT05972759· Source

• Completed

  STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

  NCT05843578· PHASE2· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· PHASE2· Source

• Completed

  A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05936151· PHASE2· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· PHASE3· Source

• Completed

  PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

  NCT05639751· PHASE1· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· PHASE2· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· PHASE2· Source

• Completed

  A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

  NCT05538572· PHASE1· Source

• Completed

  Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

  NCT05512377· PHASE2· Source

• Completed

  Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

  NCT05602454· Source

• Recruiting

  A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  NCT05498428· PHASE2· Source

• Completed

  HCW9218 for Advanced Pancreatic Cancer

  NCT05304936· PHASE1 PHASE2· Source

• Completed

  Home Blood Pressure Monitoring to Improve Hypertension

  NCT05604040· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· PHASE3· Source

• Completed

  DORAYA-HF Early Feasibility Study

  NCT05206422· Source

• Completed

  Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming

  NCT05103384· Source

• Completed

  A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms

  NCT05444530· PHASE1· Source

• Completed

  DiSCERN: Advanced PD Therapy Candidacy and Evaluation System

  NCT05351580· Source

• Completed

  A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

  NCT05218655· PHASE3· Source

• Completed

  STEM-Parkinson's Disease

  NCT04797611· Source

• Completed

  Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

  NCT05103358· PHASE2· Source

• Completed

  Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

  NCT05177211· PHASE2· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· PHASE3· Source

• Completed

  A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

  NCT05018650· Source

• Completed

  Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

  NCT04987203· PHASE3· Source

• Completed

  A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

  NCT04075916· PHASE2· Source

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· PHASE3· Source

• Completed

  Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

  NCT04827368· Source

• Completed

  Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

  NCT04697628· PHASE3· Source

• Completed

  Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

  NCT04230499· PHASE2· Source

• Completed

  Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

  NCT04547712· Source

• Completed

  Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

  NCT04417088· PHASE1 PHASE2· Source

• Completed

  Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

  NCT04602390· PHASE1· Source

• Completed

  Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT04432454· PHASE2· Source

Trial sites

• Cleveland Clinic1 trial
• Cleveland Clinic469 trials
• Cleveland Clinic3 trials
• Cleveland Clinic1 trial
• Cleveland Clinic6 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure846 works · 40 trials
• Stroke673 works · 16 trials
• Obesity535 works · 15 trials
• Atrial fibrillation400 works · 18 trials
• Lung cancer316 works · 43 trials
• Multiple myeloma275 works · 21 trials
• Type 2 diabetes264 works · 5 trials
• Chronic kidney disease249 works · 9 trials
• Alzheimer disease243 works · 5 trials
• Multiple sclerosis237 works · 10 trials
• Colorectal cancer234 works · 26 trials
• Epilepsy231 works · 14 trials
• Prostate cancer226 works · 15 trials
• Parkinson disease225 works · 23 trials
• Coronary artery disease204 works · 16 trials
• Crohn's disease199 works · 7 trials
• Melanoma193 works · 12 trials
• Acute myeloid leukemia189 works · 12 trials
• Type 1 diabetes178 works · 2 trials
• Amyloidosis165 works · 10 trials
• Sarcoma133 works · 13 trials
• Asthma131 works · 5 trials
• Ulcerative colitis129 works · 4 trials
• Myelodysplastic syndromes129 works · 9 trials
• Glioblastoma121 works · 7 trials
• Hypertrophic cardiomyopathy118 works · 8 trials
• COPD107 works · 5 trials
• Ovarian cancer100 works · 19 trials
• Hodgkin lymphoma93 works · 2 trials
• Head and neck cancer91 works · 15 trials